The temporal sequence of PTH/PTHrP receptor mRNA, binding, biologic activity, and its dependence on matrix synthesis was determined using MC3T3-El preosteoblast-like cells and primary rat calvarial cells in vitro. Osteoblastic cells were induced to differentiate and form mineralized nodules with the addition of ascorbic acid and p-glycerophosphate, and samples were collected from 0-26 days of culture. DNA levels as determined by fluorometric analysis increased 12-and 17-fold during the collection period for both MC3T3-EI and primary calvarial cells respectively. Steady state mRNA levels for the PTH/PTHrP receptor as determined by northern blot analysis, were initially low for both cell types, peaked at day 4 and 5 for MC3T3-El and primary calvarial cells respectively, and declined thereafter. Competition binding curves were performed during differentiation using 1251-PTHrP. The numbers of receptors per pg DNA were greatest at days 3 and 5 for MC3T3-El and primary calvarial cells respectively. The biologic activity of the receptor was evaluated by stimulating the cells with 10 nM PTHrP and determining cAMP levels via a binding protein assay. The PTHrP-stimulated cAMP levels increased 5-fold to peak values at day 5 for MC3T3-EI cells and 6-fold to peak values at day 4 for the primary calvarial cells. Ascorbic acid was required for maximal development of a PTH-dependent cAMP response since ascorbic acid-treated MC3T3-EI cells had twice the PTHstimulated cAMP levels as non-treated cells. When the collagen synthesis inhibitor 3,4-dehydroproline was administered to MC3T3-EI cultures prior to differentiation, there was a subsequent diminution of the PTH/PTHrP receptor mRNA gene expression and numbers of receptors per cell; however, if administered after the initiation of matrix synthesis there was no reduction in PTH/PTHrP receptor mRNA. These findings indicate that the PTH/ PTHrP receptor is associated temporally at the level of mRNA, protein, and biologic activity, with a differentiating, matrix-producing osteoblastic cell in vitro.
Parathyroid hormone (PTH) is a major regulator of systemic calcium metabolism at least in part via its interaction with cell surface receptors on osteoblastic cells [Juppner et al., 19911 . PTH-related protein (PTHrP) is an autocrine or paracrine factor that binds to the same receptor on osteoblastic cells. PTH and PTHrP have been found to have both anabolic and catabolic effects in bone; although the mechanisms of action of these two diverse effects are not known. Osteo-blasts progress through a well characterized pattern of proliferation and differentiation and are responsible for forming the mineralized matrix of bone [Lian and Stein, 19921 . Knowledge of the specific stages during differentiation in which the osteoblast is responsive to PTH and PTHrP is critical to determine the precise mechanisms of anabolic and catabolic effects of PTH and PTHrP in bone.
Numerous studies have characterized the osteoblast phenotype during cultivation of cells and production of a mineralized matrix in vitro [Malaval et al., 1994; Franceschi and Iyer, 1992; Tenenbaum and Heersche, 19821 . One of the characteristics often used to classify osteoblastic cells is the presence of PTH/PTHrP receptors or biologic response to PTH in vitro [Wong, 19901. Several studies suggest that the presence of the PTH/PTHrP receptor is associated with a specific stage of differentiation; however, there are no reports correlating the expression of the PTHI PTHrP receptor at the mRNA, ligand binding, and biologic activity levels. An in vivo autoradiographic study reported that PTH binding was localized over cells described as immature stroma1 cells [Rouleau et al., 19881 . In contrast, PTH/PTHrP receptor mRNA levels were greatest in active osteoblasts lining trabecular bone as demonstrated by in situ hybridization [Lee et al., 19941 . In vitro, it has been suggested that the PTH/PTHrP receptor is associated with a mature, cuboidal cell, and that it is expressed as osteoblastic cells differentiate Pamarnoto et al., 1988; Turksen and Aubin, 19911 ; however, detailed analysis is lacking.
Expression of other osteoblast marker proteins such as alkaline phosphatase and osteocalcin requires growth of cells in ascorbic acidcontaining medium [Franceschi and Iyer, 19921. We recently reported that the ascorbic acid requirement is related to the ability of this vitamin to stimulate collagen matrix formation since incorporation of proline analogues into procollagen that disrupt the triple-helical structure of this molecule prevented the induction of osteoblast marker protein genes [Franceschi and Iyer, 1992; Franceschi et al., 19941. It is not known if expression of the PTH/PTHrP receptor similarly requires collagen matrix synthesis.
The objectives of the present study were to determine the temporal sequence of expression and activity of the PTH/PTHrP receptor during osteoblastic differentiation in vitro and to resolve whether receptor expression requires the synthesis of a collagenous matrix. These studies provide insight into the character of cells which respond to PTH or PTHrP and may be important in designing treatment strategies for targeting anabolic actions of PTH in bone.
MATERIALS AND METHODS
Cell Culture MC3T3-El cells were obtained from Dr. M. Kumegawa (Meikai University, Sakado, Japan) and maintained as previously described [Franceschi and Iyer, 19921 . Briefly, stock cultures were grown in a-modified Eagle's medium (a-MEM) (JRH Biosciences) and 10% fetal bovine serum containing 100 units/ml of penicillin and streptomycin. Cells were passaged every 4-5 days and were not used beyond passage 15. MC3T3-El cells were plated at initial densities of 10,000/cm2 except in studies that examined the requirement for ascorbic acid and collagen synthesis on receptor expression where cells were plated at an initial density of 50,00O/cm?
Primary rat calvarial cells were isolated according to published techniques [Pockwinse et al., 19921 . Briefly, calvaria of fetal rats of 21 days gestation were dissected, isolated from periosteum, and subjected to sequential digestions of 20, 40, and 90 min in collagenase A (2 mg/ml, Boehringer-Mannheim, Indianapolis, IN) with 0.25% trypsin (Gibco BRL, Grand Island, NY).
Cells from the third digest were washed, counted, and plated in a-MEM with 10% fetal bovine serum containing 100 units/ml of penicillin and streptomycin, at a density of 20,000/cm2. Primary cultures were used without passage.
Cells were plated in either 35 mm (CAMP assays), 60 mm tissue culture dishes (RNA isolation), or 24-well plates (receptor binding assays) at an initial density of 10,000 or 20,000 cells/ cm2. After 24 h (MC3T3-El cells) or 4 days (primary calvarial cells), medium was changed to a-MEM with 10% fetal bovine serum supplemented with 50 kg/ml of ascorbic acid (Sigma) and 10 mM P-glycerophosphate (Sigma) to induce osteoblastic differentiation and mineralization in vitro. The concentration of ascorbic acid used in these experiments optimally stimulates differentiation of MC3T3-E 1 cells [Franceschi and Iyer, 19921 and saturates a recently described plasma membrane-associated ascorbate transporter [Franceschi et al., 19951 .
Northern Blot Analysis
RNA was isolated and northern blot analysis performed as described [McCauley et al., 19941 . Briefly, total RNA was isolated from one 60 mm dish by the guanidinium isothiocyanate method [Chomczynski and Sacchi, 19871 and quantitated by spectrophotometry. Total RNA (20 kg) was electrophoresed on 1.2% agarose-formaldehyde gels. The RNA was transferred to nylon membranes (Duralon U.V., Stratagene Inc. La Jolla, CA) and U.V. crosslinked. The nylon membranes were hybridized with a cDNA probe (R15B) encoding the rat PTH/PTHrP receptor [Abou-Samra et al., 19921 . After hybridization and washing, blots were exposed to Kodak X-OMAT film at -70°C for 24-72 h. Blots were also stripped and reprobed with a cDNA probe for 18s rRNA [Renkawitz and Gerbi, 19791 , to control for RNA loading.
Autoradiographs were evaluated for relative signal density with NIH Image Software and data expressed as a ratio of signal density for PTH/PTHrP receptor vs. 18s rRNA.
Receptor Binding Assays
PTH/PTHrP receptor binding assays were performed as described [McCauley et al., 1992al . Briefly, cells were plated in 24-well plates and binding assays performed at the indicated times after the introduction of ascorbic acid and P-glycerophosphate to culture media. Triplicate wells were incubated with 20,000 cpm of high performance liquid chromotography-purified monoiodinated-1251-[Tyr36]-hPTHrP amide [McCauley et al., 1992b1 , in addition to varying concentrations of nonradioactive hPTHrP (1-34) amide (Bachem Inc., Torrance, CA). The cells were incubated for 2 h at 4°C with gentle shaking. The unbound peptides were washed twice from the cell monolayer with Hank's buffered salt solution (HBSS), the cells were lysed with 0.5 M NaOH for 30 min, and the resultant suspension counted in a scintillation counter. Three wells from each plate were utilized to determine DNA levels as described using fluorimetric analysis [McCauley et al., 19951 .
Adenylate Cyclase Stimulation Assay
The adenylate cyclase stimulation assay and CAMP binding assay were performed as previously described [McCauley et al., 1992133 . Briefly, for each time point, six 35 mm dishes of MC3T3-El or primary rat calvarial cells were evaluated. Three plates were stimulated with 10 nM hPTHrP (1-34) amide, hPTH (1-34) amide (Bachem Inc.), or vehicle control as indicated for 10 min at 37°C in calcium-and magnesium-free HBSS containing 0.1% bovine serum albumin (BSA) and 1 mM isobutylmethylxanthine (IBMX). PTH and PTHrP bind to the PTH/ PTHrP receptor on osteoblastic cells with similar binding affinity and biologic activity [Jiippner et al., 19881 . The media was aspirated and 750 p,1 ice-cold 5% perchloric acid was added to each well. The plates were incubated at -20°C overnight to extract the CAMP. After thawing, the extract was transferred to tubes, the pH was adjusted to 7.5 with 4N KOH, and the extract was centrifuged to remove the precipitate. The neutralized extract was then assayed for CAMP content using a CAMP binding protein assay.
Parallel wells were analyzed for DNA content by fluorimetric analysis as described above.
The CAMP binding protein assay was performed as follows. To each tube was added assay buffer (50 mM Tris, 5 mM EDTA, pH 7.41, 100 p,1 standards or unknowns, [3Hl-cAMP (10,000 cpm/tube), and CAMP binding protein sufficient to bind 40-60% of the radioactivity in a final volume of 250 p,l. The tubes were incubated for 90 min on ice. Dextran-coated charcoal (0.5 mg/ml dextran and 5.0 mg/ml charcoal) was added to each tube (600 p,l), incubated an additional 30 min on ice, then centrifuged to remove the unbound from the bound CAMP-binding protein-[3H]-cAMP complexes. The supernatant was decanted directly into scintillation vials and counted in a liquid scintillation spectrophotometer. Samples were run in duplicate and the concentration of CAMP was calculated by the log-logit method using Securia 1.0 (Packard Instruments, Indianapolis, IN). Data were expressed as pmol cAMP/p,g DNA or as a ratio of T/C (PTH-stimulated vs. vehicle control).
Statistical Analysis
Data for the adenylate cyclase assays were evaluated using Instat 1.1 (GraphPAD Software, Inc., San Diego, CA) and an MS/DOS computer. Analysis of variance followed by multiple comparisons using a Tukey's mean separation test were used to determine statistically significant (P < 0.05) differences between groups. Nonlinear regression of the binding curve for PTHrP was performed with Prism@ (Graph Pad Software, San Diego, CA) using nonlinear curve fitting. Autoradiographs from the northern blot analysis were evaluated for relative signal density with NIH Image Software on a MacIntosh computer.
RESULTS
MC3T3-El cells were plated and allowed to attach overnight. The next day fresh media containing ascorbic acid and P-glycerophosphate was added. The first few days was a period of rapid proliferation. The cells reached confluence by day 3-4 but continued to proliferate as reflected by a 12-fold increase in cellular DNA through the culture period (Fig. 1) . Since the primary calvarial osteoblasts were isolated directly from fetal calvaria subjected to collagenase digestion, a longer acclimation period was allowed prior to the addition of ascorbic acid and P-glycerophosphate (2-3 day). The DNA levels at day 0 were similar to the MC3T3-El cells, however, slightly higher and increased 17-fold over the 26 day culture period. Steady state mRNA levels for the PTH/PTHrP receptor in MC3T3-El cells were initially low, and increased 4-fold to peak levels at day 4 (Fig. 2) . Subsequently, mRNA levels for the PTH/PTHrP receptor gradually declined through the culture period. The primary calvarial cells followed a similar pattern with a 3-fold increase in PTH/PTHrP receptor steady state mRNA reaching a peak at day 5, and declining thereafter. To determine whether there was an alteration in the number of receptors or the binding f i nity of PTH/PTHrP receptors during differentiation, competition binding curves were performed at various time points during the culture period. Figure 3 contains binding curves for MC3T3-El cells during differentiation. There was specific binding of PTHrP to MC3T3-El cells at all time points during the culture period; however, initially the binding curve was relatively flat. Peak levels of cpm specifically bound to MC3T3-El cells occurred at day 7. Further increases in total binding were attributed to a concomitant increase in non-specific binding. The EC50 and number of receptors per kg DNA are listed in Table I , and account for the alterations in cell number during the culture period. For the early time periods the levels of binding were too low to obtain accurate EC50 and B, , values. During the culture period the EC50 values were similar, with the highest affinity reached at day 14; however, the number of receptors per cell was highest at day 3 and was lower at day 14. Similar results were found for the primary calvarial cells. The binding affinity was highest at day 12; however, the numbers of Table I . *Calculated using nonlinear regression and Scatchard analysis o f data from competition binding curves depicted in Figure 3 .
receptors was greatest at day 5 ( Fig. 4 and Table  11 ). In order to correlate biologic activity with the presence of the PTHiPTHrP receptor, an evaluation of PTHrP-stimulated CAMP levels during differentiation was performed. The data reported in Figure 5 , is expressed as a ratio of T (PTHrP stimulated samples) vs. C (non-stimulated) since there were slight increases in basal CAMP levels during the culture period. DNA for the MC3T3-El and primary calvarial cells respectively. The PTHrP-stimulated CAMP levels in MC3T3-El cells were initially low and increased 5-fold to peak values at day 5 and decreased thereafter. The PTHrP-stimulated CAMP levels in the primary calvarial osteoblasts were also low initially and increased 6-fold with a peak at day 4 and subsequently decreased to below initial values from day 17-26. The studies reported in Figures 6-8 and Iyer, 1992; Franceschi et al., 19941 . In the experiment in Figure 6 , cells were grown for 3 days in control and ascorbic acid-containing medium before CAMP production in the presence and absence of PTH was measured. Ascorbic acid did not affect basal CAMP levels, but doubled PTH-dependent CAMP production. Figure 7 indicates that collagen synthesis is also required for the expression of the PTH/PTHrP receptor. Control and ascorbic acid-treated MC3T3-E 1 cells were grown in the presence or absence of 3,4-dehydroproline (3,4-DHP), a specific inhibitor of triple-helical collagen formation. Ascorbic acid increased receptor mRNA 4-fold after 6 days and this stimulation persisted to day 8 and 10. In contrast, if 3,4-DHP was added with ascorbic acid at the start of the experiment, no stimulation of the PTH/PTHrP message was detected. However, if cells were pretreated with ascorbic acid for 6 days before inhibitor addition, no block in mRNA induction was seen after 2 or 4 additional days. Similar results were found for the effects of ascorbic acid and 3,4-DHP on 1251-PTHrP binding to PTH/PTHrP receptors in MC3T3-El cells (Fig. 8) . Competition binding curves indicate that the EC50 values were not altered for the indicated treatment conditions. However, the numbers of receptors were higher for the ascorbic acid-treated cells, and inhibition of collagen synthesis with 3,4-DHP resulted in a reduction in receptor numbers to control values. Our previous work established that the concentration of 3,4-DHP used in this experiment (500 p,M) blocks greater than 95% of total type I collagen synthesis [Franceschi et al., 19941 . Actions of this inhibitor are fully reversible and not associated with cellular toxicity. This was further substantiated since there was no significant difference in the DNA levels for the DHP treatment groups depicted in Figure 8 (data not shown).
DISCUSSION
The process of osteoblast differentiation has been characterized with a stepwise sequence of expression for phenotypic mineral-associated proteins [Lian and Stein, 19921 . Other studies have described the sequence of gene expression for osteocalcin, osteopontin, H4 histone, bone sialoprotein, c-fos, type I collagen, and alkaline phosphatase and related these phenotypic characteristics with matrix synthesis and the accumulation of calcium and phosphate in mineralized nodules [Kockx et al., 1994; Machwate et al., 1995; Ibaraki et al., 1992; Franceschi and Iyer, 19921 . Studies of this type provide valuable
Ascorbic Acid _i-"-" Experimental outline: MC3T3-El cells were grown for 6 days in control medium (6C), control medium containing 500 FM 3,4-DHP (6CD), medium containing 50 pg/mL ascorbic acid (6A) or ascorbic acid-containing medium plus 3,4-DHP (6AD). Some control cultures were grown for an additional 2 ( 8 C ) or 4 (70C) days. At day 6, ascorbic acid-treated cells were divided information which has contributed to the understanding of osteoblast function. The present study determined the temporal pattern of gene expression, protein binding, and biologic activity for the PTH/PTHrP receptor in two calvarial osteoblastic cell systems. The MC3T3-E 1 cells are a well-characterized immortalized osteoblastic cell line which undergo a specified pattern of differentiation in vitro [Franceschi and Iyer, 19921 . Primary rat calvarial cells were also utilized since these cells are used extensively in mineralized tissue research as a model of differentiation.
The results of the present study indicate that the PTHiPTHrP receptor is initially expressed in low to undetectable levels in both culture systems, and requires several days of differentiation induced by ascorbic acid for maximal expression. This is an important finding since many studies in the past have used the presence of a PTH/PTHrP receptor as an indication that a cell is of the osteoblast lineage. The data presented in this investigation indicate that the time period of PTH/PTHrP receptor expression is dependent temporally on the differentiation state of the cell. Consequently, an immature osteoblastic cell or an inactive osteoblastic cell should not be discarded as being of the osteoblast lineage if it is not actively responding to PTH; however, a PTH-response may reflect the differentiation state of the osteoblast. [19891 described the isolation and immortalization of two rat calvarial cell lines, RCT-1 and RCT-3. The RCT-1 cells were described as immature and displayed a PTH-stimulated CAMP response only after 3 days of retinoic acid induced differentiation. The RCT-3 cells were described as active osteoblasts and constitutively displayed a PTH-stimulated CAMP. These findings support the concept that immature osteoblastic cells are dependent on differentiation for the expression and function of the PTHiPTHrP receptor.
In the present study, the highest numbers of receptors correlated with the maximal CAMP response. The small apparent variation in EC50 values for ligand binding (2-3-fold) are probably not significant. Instead, CAMP levels correlated with receptor number and not binding affinity.
The peak values of PTH/PTHrP receptor binding and biologic activity also coincided with the time period in which active matrix synthesis is initiated. This indicates that the synthesis of matrix surrounding the osteoblasts may regulate expression and activity of the PTH/PTHrP receptor as has been reported for other osteoblast markers [Franceschi and Iyer, 1992; Franceschi et al., 19941 . Consistent with this possibility, ascorbic acid strongly stimulated PTH/ PTHrP receptor mRNA levels and PTHdependent CAMP production. Furthermore, the ascorbic acid-dependent induction of receptor mRNA and lZ51-PTHrP binding activity was completely blocked by a specific inhibitor of collagen matrix synthesis, 3,4-dehydroproline. This proline analog is incorporated into type I procollagen where it inhibits hydroxylation, triple helix formation, and subsequent extracellular matrix deposition [Vitto and Prockop, 19751 . If inhibitor addition was delayed until cells had already begun to form a collagenous matrix (day 6), further suppression of matrix production no longer interfered with receptor mRNA expression. This result is similar to our previous findings with alkaline phosphatase and osteocalcin and suggests that short periods of collagen matrix synthesis generate a stable inductive signal for osteoblast marker gene expression. This signal may be generated by interactions between the extracellular matrix and cell surface receptors such as integrins or other components present in the matrix of ascorbic acid-treated cells.
In summary, the data presented here indicate that the PTH/PTHrP receptor is associated temporally at the level of mRNA, protein and biologic activity with a differentiating, matrixproducing osteoblastic cell in vitro.
